# Desvenlafaxine

NDC: 70436-013
Generic name: Desvenlafaxine
Labeler / Manufacturer: Slate Run Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20200801

FDA application: ANDA210014

## Active ingredients

- DESVENLAFAXINE SUCCINATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70436-013"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70436-013
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44f4b928-d5b8-44e7-bfa6-81fb0dc1a718